VBI VACCINES
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
VBI VACCINES
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vbivaccines.com
Total Employee:
101+
Status:
Active
Contact:
16137384178
Email Addresses:
[email protected]
Total Funding:
536.97 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Person Schema Microsoft Amazon S3 AmCharts
Similar Organizations
ACEA BIO
ACEA Biosciences is a biotechnology company that develops and commercializes high-performance microelectronic systems for cell-based assays.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
ImaginAb
ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Neurovance
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Rational Vaccines
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-09-15 | Epixis | Epixis acquired by VBI Vaccines | N/A |
Investors List
Brii Biosciences
Brii Biosciences investment in Post-IPO Equity - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
Strategic Innovation Fund
Strategic Innovation Fund investment in Grant - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
Pontifax
Pontifax investment in Post-IPO Equity - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - VBI Vaccines
OPKO Health
OPKO Health investment in Post-IPO Equity - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - VBI Vaccines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer |
Official Site Inspections
http://www.vbivaccines.com Semrush global rank: 3.14 M Semrush visits lastest month: 4.82 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VBI Vaccines"
VBI Vaccines Inc. - LinkedIn
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like ...See details»
VBI Vaccines - Wikipedia
Variation Biotechnologies Inc. (VBI), also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty researchers working with National Research Council of Canada (NRC) to produce a COVID-19 vaccine—VBI-2902. In August VBI received CA$56 million from the Gover…See details»
VBI Vaccines - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 16137384178 VBI Vaccines is a biopharmaceutical company developing novel technologies that …See details»
CCAA Records VBI Vaccines Inc., et al. - ised-isde.canada.ca
900 boul. De Maisonneuve O., Bureau 2300, Montréal, Québec, Canada, H3A 0A8See details»
VBI Vaccines - 2025 Company Profile - Tracxn
Jun 16, 2025 VBI Vaccines has raised a total funding of $65.1M over 23 rounds. Its first funding round was on Jan 04, 2007. Its latest funding round was a Grant (prize money) round on Aug …See details»
VBI Vaccines (VBIVQ) Company Profile & Description - Stock Analysis
Jan 13, 2025 VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) …See details»
VBI Vaccines Provides an Update on its Restructuring ... - Newswire
CAMBRIDGE, Mass., Dec. 10, 2024 /CNW/ - VBI Vaccines Inc. ("VBI" or the "Company") today provided an update on the restructuring proceedings announced on July 30, 2024. …See details»
VBI Vaccines Announces Expanded Strategic Partnership with …
Apr 2, 2024 Currently, Dr. Grabenstein is president of consulting service Vaccine Dynamics SP, and is also Associate Director of Scientific Communications for the Immunization Action …See details»
VBI Vaccines Awarded Up to CAD$56 Million Contribution from …
Aug 5, 2020 Variation Biotechnologies Inc., an Ottawa-based wholly-owned Canadian subsidiary of VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharSee details»
An enveloped virus-like particle vaccine expressing a ... - PubMed
Aug 16, 2021 Affiliations 1 Bionaria, 11Bis Rue de la Garenne, 69290 Saint-Genis-les-Ollières, France. Electronic address: [email protected]. 2 VBI Vaccines, 201-310 Hunt Club …See details»
VBI Vaccines Announces Completion of Sales Process to K2
CAMBRIDGE, Mass., Jan. 3, 2025 /CNW/ - VBI Vaccines Inc. ("VBI" or the "Company") today announced, that, in connection with its creditor protection proceedings under the Companies' …See details»
VBI Vaccines Provides an Update on its Restructuring Proceedings …
CAMBRIDGE, Mass. – December 10, 2024 – VBI Vaccines Inc. (“VBI” or the “Company”) today provided an update on the restructuring proceedings announced on July 30, 2024. …See details»
About Us - VBI Vaccines
She has served as an advisor to the World Health Organization, USAID, the Wellcome Trust, and the European Forum for Good Clinical Practice, among others. She contributes to several …See details»
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst ...
Feb 23, 2023 Email: [email protected]. Cautionary Statement on Forward-looking Information ... and telesales organization, with full P&L responsibility delivering over $3 billion …See details»
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase …
Mar 9, 2021 Email: [email protected]. References ... (IAC), a non-profit organization working to increase immunization rates and prevent disease by creating and distributing educational …See details»
Our Pipeline - VBI Vaccines
She has served as an advisor to the World Health Organization, USAID, the Wellcome Trust, and the European Forum for Good Clinical Practice, among others. She contributes to several …See details»
Gavi, the Vaccine Alliance: 25 years in 25 moments
3 days ago 1. 2000: Gavi, the Vaccine Alliance is launched. At the dawn of the new millennium, a new kind of global health organisation was born. Launched in Davos, Switzerland, in …See details»
VBI Vaccines Announces Expanded Strategic Partnership with …
Apr 2, 2024 VBI Contact Nicole Anderson Director, Corporate Communications & IR Phone: (617) 830-3031 x124 Email: [email protected] Source: VBI Vaccines Inc. Analyze your …See details»
VBI Vaccines Announces Initial Positive Phase 1 Data for Its eVLP ...
Jun 29, 2021 VBI Nicole Anderson Director, Corporate Communications & IR (617) 830-3031 x124 [email protected] Contacts VBI Nicole Anderson Director, Corporate …See details»
Global vaccine group Gavi has $9 billion, short of its target
1 day ago Global vaccine group Gavi has more than $9 billion for its work over the next five years helping to immunize the world's poorest children, including money raised at a Brussels …See details»